Quality Resource Guide
l
Contemporary Approaches to Antibiotic Prophylaxis 1st Edition
6
www.metdental.com
References
1.
Ortman JB, Velkoff VA, and Hogan H.
An Aging Nation:
The Older Population in the United States Population
Estimates and Projections Census.gov accessed July
31st, 2017.
2.
Miller CS, Epstein JB, Hall EH, Sirois D. Changing oral
care needs in the United States: The continuing need
for oral medicine Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2001; 91:34-44.
3.
Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci
EL. Trends in Prescription Drug Use Among Adults in
the United States From 1999-2012. JAMA 2015 Nov 3;
314(17): 1818-31.
4.
Lockhart PB, Loven B, Brennan MT, Baddour LM,
Levinson M. The evidence base for the efficiency of
antibiotic prophylaxis in dental practice. J Am Dent
Assoc 2007; 138(4): 458-74
5.
Lockhart PB, Brennan MT, Fox PC, Norton HJ,
Jernigan DB, Strausbaugh LJ. Decision-making on the
use of antimicrobial prophylaxis for dental procedures:
a survey of infectious disease consultants and review.
Clin Infect Dis. 2002; 34(12): 1621-1626
6.
Parahitiyawa NB, Jin LJ, Leung WK, Yam WC,
Samaranayake LP. Microbiology of odontogenic
bacteremia: Beyond endocarditis. Clinical Microbiology
Reviews. 2009; 22(1): 46-64.
7.
Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster
BJ, Bahrani-Mougeot FK. Bacteremia associated with
toothbrushing and dental extraction. Circulation. 2008;
117(24): 3118-3125.
8.
Lockhart PB, Brennan MT, Thornhill M, Michalowicz
BS, Noll J, Bahrani-Mougeot FK, Sasser H. Poor oral
hygiene as a risk factor for infective endocarditis-
related bacteremia. J Am Dent Assoc. 2009 Oct;
140(10): 1238-44
9.
Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers
JB, Dayer M, et al. Antibiotic prophylaxis for infective
endocarditis: a systematic review and meta-analysis.
Heart 2017;103:937–44.
10.
Gary CJ, Glick M. Medical clearance: An issue of
professional autonomy, not a crutch. J Am Dent Assoc.
2012;143(11):1180–1181.
11.
Infective Endocarditis Brusch JL, Bronze MS, Ed.
12.
Bor DH, Woolhandler S, Nardin R, Brusch J,
Himmelstein DU. Infective endocarditis in the U.S.,
1998-2009: a nationwide study. PLoS One. 2013.
8(3):e60033.
13.
Prevention of infective endocarditis: Guidelines from
the American Heart Association. Wilson, et al. Jan
2008. J Am Dent Assoc., Volume 139, S3 - S24
14.
Nishimura RA, Otto CM, Bonow RO, Carabello BA,
Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod
CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson
A. 2017 AHA/ACC focused update of the 2014 AHA/
ACC guideline for the management of patients with
valvular heart disease: A report of the American
College of Cardiology/American Heart Association
Task Force on Clinical Practice Guidelines. Circulation.
2017; 135:e1159-e1195
15.
Wilson W, Taubert KA, Gewitz M, et al. American
Heart Association Rheumatic Fever, Endocarditis,
and Kawasaki Disease Committee, American Heart
Association Council on Cardiovascular Disease in the
Young, American Heart Association Council on Clinical
Cardiology, American Heart Association Council on
Cardiovascular Surgery and Anesthesia, Quality
of Care and Outcomes Research Interdisciplinary
Working Group. Prevention of infective endocarditis:
Guidelines from the American Heart Association:
A guideline from the American Heart Association
Rheumatic
Fever,
Endocarditis,
and
Kawasaki
Disease Committee, Council on Cardiovascular
Disease in the Young, and the Council on Clinical
Cardiology, Council on Cardiovascular Surgery and
Anesthesia, and the Quality of Care and Outcomes
Research Interdisciplinary Working Group. Circulation
2007;116:1736–54
16.
American Dental Association–Appointed Members of
the Expert Writing and Voting Panels Contributing to
the Development of American Academy of Orthopedic
Surgeons Appropriate Use Criteria.
J Am Dent Assoc.
2017 Feb;148 (2):57-59.
17.
Tande AJ, Patela R. Prosthetic joint infection. Clin
Microbiol Rev. 2014;27(2):302-345.
18.
Lamagni T. Epidemiology and burden of prosthetic
joint infections. J Antimicrob Chemother. 2014;69(suppl
1):i5-i10.
19.
L. Legout, E. Beltrand, H. Migaud, E. Senneville.
Antibiotic prophylaxis to reduce the risk of joint
implant contamination during dental surgery seems
unnecessary. Orthopaedics & Traumatology: Surgery
& Research. 2012;98(8):910-914.
20.
Témoin S, Chakaki A, Askari A, et al. Identification of
oral bacterial DNA in synovial fluid of arthritis patients
with native and failed prosthetic joints. Journal of Clinical
Rheumatology : Practical Reports on Rheumatic &
Musculoskeletal Diseases. 2012;18(3):117-121.
21.
American Dental Association and American Academy
of Orthopedic Surgeons. Antibiotic prophylaxis for
dental patients with total joint replacements 2003. J Am
Dent Assoc;134(7):895 – 898.
22.
American Academy of Orthopedic Surgery. Information
Statement 1033: Antibiotic Prophylaxis for Bacteremia
in Patients with Joint Replacements. February 2009.
American Academy of Orthopedic Surgeons.
23.
Watters W, Rethman MP, Hanson NB, Abt E, Anderson
PA, et al. Prevention of orthopedic implant infection in
patients undergoing dental procedures. J Am Acad
Orthop Surg. 2013;21(3):180-189.
24.
Sollecito TP, Abt E, Lockhart PB, Truelove E, Paumier
TM, et al. The use of prophylactic antibiotics prior
to dental procedures in patients with prosthetic
joints: evidence-based clinical practice guideline
for dental practitioners—a report of the American
Dental Association Council on Scientific Affairs. JADA.
2015;146(1):11-16.
25.
Centers for Disease Control: Nearly half a million
Americans suffered from Clostridium difficile infections
in a single year: Accessed July 31st,2017 http://www.
cdc.gov/media/releases/2015/p0225-clostridium-
difficile.html
26.
Bartlett JG. Narrative review: the new epidemic of
Clostridium difficile-associated enteric disease. Ann
Intern Med. 2006;145(10):758-764.
27.
Lockhart PB, Blizzard J, Maslow AL, Brennan MT,
Sasser H, Carew J. Drug cost implications for
antibiotic prophylaxis for dental procedures. Oral Surg
Oral Med Oral Pathol Oral Radiol. 2013;115(3):345-
353.
28.
Berbari EF, Osmon DR, Carr A, et al. Dental
procedures as risk factors for prosthetic hip or knee
infection: a hospital-based prospective case control
study (published correction appears in Clin Infect Dis.
2010;50(6):944). Clin Infect Dis. 2010;50(1):8-16.
29.
American Academy of Orthopaedic Surgeons
(AAOS). Appropriate use criteria for the
management of patients with orthopaedic implants
undergoing dental procedures. Rosemont, IL:
AAOS; 2016. Available at: www.orthoguidelines.org/
go/auc.
Table 4
15
Special Considerations
•
Patients who are at risk for IE can receive any indicated dental care
•
Coronary artery bypass graft (CABG) or coronary artery stents (after endothelialization) do not routinely require antibiotic prophylaxis
prior to dental treatment
•
If unanticipated bleeding occurs in a patient at risk for endocarditis, prophylaxis should be given within 2 hours of the procedure to be
effective
•
If a patient is taking oral penicillin for other purposes, clinicians should consider clindamycin for prophylaxis to cover any penicillin-
resistant streptococci
NOTE:
If a patient is already receiving chronic antibiotic therapy with an antibiotic that is also recommended for IE prophylaxis, it is prudent to select an
antibiotic from a different class rather than to increase the dosage of the current antibiotic or preferably delay dental treatment for 10 days after completion of
the antibiotic therapy to allow time for the usual oral flora to be re-established.